PMC:7091888 / 5548-5893
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 259 | 14-24 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
| 260 | 29-37 | Species | denotes | SARS-CoV | Tax:694009 |
| 261 | 62-70 | Species | denotes | SARS-CoV | Tax:694009 |
| 262 | 284-292 | Species | denotes | SARS-CoV | Tax:694009 |
| 263 | 322-332 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T28 | 337-344 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T104 | 14-22 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T105 | 14-18 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T106 | 29-37 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T107 | 29-33 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T108 | 62-70 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T109 | 62-66 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T110 | 284-292 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T111 | 284-288 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T112 | 322-330 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T113 | 322-326 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T33 | 337-344 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T21 | 0-345 | Sentence | denotes | Notably, only SARS-CoV-2 and SARS-CoV RBDs were recognized by SARS-CoV RBD-specific, but not MERS-CoV RBD-specific, polyclonal antibodies (Fig. 1c), whereas only MERS-CoV RBD was recognized by MERS-CoV RBD-immunized polyclonal antibodies (Fig. 1d), suggesting the cross-reactivity of SARS-CoV RBD-specific antibodies with SARS-CoV-2 RBD protein. |